Evidence map›Paper›PMID 33198763›Full record

ArticleAlzheimer's research & therapy2020

Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice.

Debora Cutuli, Eugenia Landolfo, Annalisa Nobili, Paola De Bartolo, Stefano Sacchetti, Doriana Chirico, Federica Marini, Luisa Pieroni, Maurizio Ronci, Marcello D'Amelio and 3 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  6. Review
  7. Omega-3 Polyunsaturated Fatty Acids in Depression.International journal of molecular sciences · 2024
    Review
  8. Essential role of p21Stem cell research & therapy · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Debora CutuliIRCCS Fondazione Santa Lucia, Rome, Italy. debora.cutuli@uniroma1.it.ORCID 0000-0003-4788-2461
Eugenia LandolfoIRCCS Fondazione Santa Lucia, Rome, Italy.
Annalisa NobiliIRCCS Fondazione Santa Lucia, Rome, Italy.
Paola De BartoloIRCCS Fondazione Santa Lucia, Rome, Italy.
Stefano SacchettiUniversity of Rome "Sapienza", Rome, Italy.
Doriana ChiricoInstitute of Biochemistry and Cell Biology, CNR, Monterotondo, Italy.
Federica MariniUniversità Cattolica del Sacro Cuore, Rome, Italy.
Luisa PieroniIRCCS Fondazione Santa Lucia, Rome, Italy.
Maurizio RonciDepartment of Pharmacy, University G. D'Annunzio of Chieti-Pescara, Chieti, Italy.
Marcello D'AmelioIRCCS Fondazione Santa Lucia, Rome, Italy.
Francesca Romana D'AmatoInstitute of Biochemistry and Cell Biology, CNR, Monterotondo, Italy.
Stefano Farioli-VecchioliInstitute of Biochemistry and Cell Biology, CNR, Monterotondo, Italy.
Laura PetrosiniIRCCS Fondazione Santa Lucia, Rome, Italy.
Fondazione Santa Lucia · ITInstitute of Cell Biology and Neurobiology · ITUniversità Campus Bio-Medico · ITMarconi University · ITSapienza University of Rome · ITUniversità Cattolica del Sacro Cuore · ITUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, mechanistic, epidemiologic, and interventional studies have indicated beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFA) against brain aging and age-related cognitive decline, with the most consistent effects against Alzheimer's disease (AD) confined especially in the early or prodromal stages of the pathology. In the present study, we investigated the action of n-3 PUFA supplementation on behavioral performances and hippocampal neurogenesis, volume, and astrogliosis in aged mice subjected to a selective depletion of basal forebrain cholinergic neurons. Such a lesion represents a valuable model to mimic one of the most reliable hallmarks of early AD neuropathology.

methodsAged mice first underwent mu-p75-saporin immunotoxin intraventricular lesions to obtain a massive cholinergic depletion and then were orally supplemented with n-3 PUFA or olive oil (as isocaloric control) for 8 weeks. Four weeks after the beginning of the dietary supplementation, anxiety levels as well as mnesic, social, and depressive-like behaviors were evaluated. Subsequently, hippocampal morphological and biochemical analyses and n-3 PUFA brain quantification were carried out.

resultsThe n-3 PUFA treatment regulated the anxiety alterations and reverted the novelty recognition memory impairment induced by the cholinergic depletion in aged mice. Moreover, n-3 PUFA preserved hippocampal volume, enhanced neurogenesis in the dentate gyrus, and reduced astrogliosis in the hippocampus. Brain levels of n-3 PUFA were positively related to mnesic abilities.

conclusionsThe demonstration that n-3 PUFA are able to counteract behavioral deficits and hippocampal neurodegeneration in cholinergically depleted aged mice promotes their use as a low-cost, safe nutraceutical tool to improve life quality at old age, even in the presence of first stages of AD.

Indexed as

Alzheimer DiseaseBasal ForebrainFatty Acids, Omega-3AnimalsCholinergic AgentsHippocampusMiceCholinergic AgentsFatty Acids, Omega-3AgingAlzheimer’s diseaseCholinergic systemDietMemory deficitsOmega-3 fatty acids

Identifiers

PMID33198763
PMCPMC7667851
OpenAlexW3099991442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.